These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 11361880)

  • 1. Characteristics and treatment of hepatitis C virus infection in HIV-coinfected subjects.
    Zylberberg H; Pol S
    AIDS Patient Care STDS; 1998 Jan; 12(1):11-9. PubMed ID: 11361880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus and hepatitis C virus coinfection.
    Rockstroh JK; Woitas RP; Spengler U
    Eur J Med Res; 1998 Jun; 3(6):269-77. PubMed ID: 9620887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
    Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J
    Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
    Kumar R; Singla V; Kacharya Sk
    Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV and hepatitis C virus coinfection: bad bedfellows.
    Schooley RT
    Top HIV Med; 2005; 13(4):112-6. PubMed ID: 16304454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD81 expression in peripheral blood lymphocytes before and after treatment with interferon and ribavirin in HIV/HCV coinfected patients.
    Micheloud D; González-Nicolás J; Berenguer J; Lorente R; Miralles P; López JC; Cosín J; Catalán P; Muñoz-Fernández M; Resino S
    HIV Med; 2010 Mar; 11(3):161-9. PubMed ID: 19780859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for managing hepatitis C virus infection in HIV-infected patients.
    Clanon KA
    Top HIV Med; 2003; 11(2):50-4. PubMed ID: 12717042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of chronic hepatitis C virus infection with interferon in patients infected with the human immunodeficiency virus].
    Sánchez JF; Pascua J; Sánchez F; Crespo L; Briones A; Martín C
    An Med Interna; 1994 Dec; 11(12):575-9. PubMed ID: 7734662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of hepatitis C virus coinfection in HIV-infected persons.
    O'Leary JG; Chung RT
    AIDS Read; 2006 Jun; 16(6):313-6, 318-20. PubMed ID: 16795921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus NS3/4A quasispecies diversity in acute hepatitis C infection in HIV-1 co-infected patients.
    Nevot M; Boesecke C; Parera M; Andrés C; Franco S; Revollo B; Ingiliz P; Tural C; Clotet B; Rockstroh JK; Martinez MA;
    J Viral Hepat; 2014 Jun; 21(6):e19-28. PubMed ID: 24674023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coinfection with human immunodeficiency virus and hepatitis C virus: challenges and therapeutic advances. Insights from the Society of Infectious Diseases Pharmacists.
    Deming P; McNicholl IR
    Pharmacotherapy; 2011 Apr; 31(4):357-68. PubMed ID: 21449625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus (HCV) protease variability and anti-HCV protease inhibitor resistance in HIV/HCV-coinfected patients.
    Trimoulet P; Belzunce C; Faure M; Wittkop L; Reigadas S; Dupon M; Ragnaud JM; Fleury H; Neau D
    HIV Med; 2011 Sep; 12(8):506-9. PubMed ID: 21410862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
    Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
    Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus and human immunodeficiency virus: a dangerous dealing.
    Pellicano R; Fagoonee S; Repici A; Rizzetto M
    Panminerva Med; 2007 Jun; 49(2):79-82. PubMed ID: 17625484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of HIV sustained viral suppression in HIV/hepatitis C virus coinfected patients: possible role of the hepatitis C virus sustained viral response.
    Bani-Sadr F; Loko MA; Pambrun E; Winnock M; Carrieri P; Gilbert C; Duvivier C; Bouchaud O; Gervais A; Dabis F; Salmon D;
    AIDS; 2014 May; 28(8):1155-60. PubMed ID: 24499953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy with interferon in HIV-infected patients with chronic viral hepatitis].
    Soriano V; García-Samaniego J
    Rev Clin Esp; 1994 Oct; 194(10):887-9. PubMed ID: 7528439
    [No Abstract]   [Full Text] [Related]  

  • 17. Intrafamilial transmission of hepatitis C virus in patients with hepatitis C and human immunodeficiency virus coinfection.
    Keiserman DR; Both CT; Mattos AA; Remiao J; Alexandre CO; Sherman KE
    Am J Gastroenterol; 2003 Apr; 98(4):878-83. PubMed ID: 12738471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus genetic variability in 52 human immunodeficiency virus-coinfected patients.
    Neau D; Jouvencel AC; Legrand E; Trimoulet P; Galperine T; Chitty I; Ventura M; Le Bail B; Morlat P; Lacut JY; Ragnaud JM; Dupon M; Fleury H; Lafon ME
    J Med Virol; 2003 Sep; 71(1):41-8. PubMed ID: 12858407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of insulin resistance in HIV/hepatitis C virus-coinfected patients.
    Eslam M; López-Cortés LF; Romero-Gomez M
    Curr Opin HIV AIDS; 2011 Nov; 6(6):553-8. PubMed ID: 21934619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus (HCV) genotypes and disease progression in HIV/HCV-coinfected patients.
    Núñez M; Soriano V
    J Infect Dis; 2005 Jan; 191(1):1-3. PubMed ID: 15592995
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.